Leukemia, Myeloid  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
NCT01295710: Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Checkmark For moderate to severe chronic graft-versus-host-disease
Oct 2017 - Oct 2017: For moderate to severe chronic graft-versus-host-disease
Completed
3
260
US, RoW
US-ATG-F, Anti-human-T-lymphocyte Immune Globulin, Rabbit, Placebo
Neovii Biotech
GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
10/15
10/15
GLOBAL, NCT00354120 / 2005-000805-68: Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Completed
2/3
121
Europe
Alentuzumab, Globulina antilinfocitaria
Gruppo Italiano Trapianto di Midollo Osseo
Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Myelofibrosis, Lympho-proliferative Diseases
08/11
08/11

Download Options